These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29511023)

  • 41. TAZ inhibits glucocorticoid receptor and coordinates hepatic glucose homeostasis in normal physiological states.
    Xu S; Liu Y; Hu R; Wang M; Stöhr O; Xiong Y; Chen L; Kang H; Zheng L; Cai S; He L; Wang C; Copps KD; White MF; Miao J
    Elife; 2021 Oct; 10():. PubMed ID: 34622775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of YAP function overcomes BRAF inhibitor resistance in melanoma cancer stem cells.
    Fisher ML; Grun D; Adhikary G; Xu W; Eckert RL
    Oncotarget; 2017 Dec; 8(66):110257-110272. PubMed ID: 29299145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-Wide Characterization of TAZ Binding Sites in Mammary Epithelial Cells.
    Liu T; Zhou J; Chen Y; Fang J; Liu S; Frangou C; Wang H; Zhang J
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tankyrase inhibition interferes with junction remodeling, induces leakiness, and disturbs YAP1/TAZ signaling in the endothelium.
    Ma N; Wibowo YC; Wirtz P; Baltus D; Wieland T; Jansen S
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1763-1789. PubMed ID: 37741944
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of YAP1 and TAZ expression by immunohistochemical staining in malignant mesothelioma and reactive mesothelial cells.
    Takehara Y; Yamochi T; Nagumo T; Cho T; Urushibara F; Ono K; Fujii T; Okamoto N; Sasaki Y; Tazawa S; Honma M; Norose T; Shiozawa E; Tate G; Takimoto M
    Oncol Lett; 2018 May; 15(5):6825-6830. PubMed ID: 29731861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chloroacetamide fragment library screening identifies new scaffolds for covalent inhibition of the TEAD·YAP1 interaction.
    Bum-Erdene K; Ghozayel MK; Zhang MJ; Gonzalez-Gutierrez G; Meroueh SO
    RSC Med Chem; 2023 Sep; 14(9):1803-1816. PubMed ID: 37731696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Research progress on Hippo signaling pathway effector molecules in rheumatic immune system diseases.
    Gao J; Pi C; Pan J; Zhou W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 53(3):376-381. PubMed ID: 38899353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.
    Sekido Y
    Cancers (Basel); 2018 Mar; 10(4):. PubMed ID: 29565815
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-fat and high-glucose microenvironment decreases Runx2 and TAZ expression and inhibits bone regeneration in the mouse.
    Wu X; Zhang Y; Xing Y; Zhao B; Zhou C; Wen Y; Xu X
    J Orthop Surg Res; 2019 Feb; 14(1):55. PubMed ID: 30777111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Yes Associated Transcriptional Regulator 1 (YAP1) and WW Domain Containing Transcription Regulator (WWTR1) are required for murine pregnancy initiation.
    Moldovan GE; Massri N; Vegter E; Pauneto-Delgado IL; Burns GW; Joshi N; Gu B; Arora R; Fazleabas AT
    bioRxiv; 2024 May; ():. PubMed ID: 38766130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring the Role of YAP1 and TAZ in Pancreatic Acinar Cells and the Therapeutic Potential of VT-104 in Pancreatic Inflammation.
    Lopez K; Deng JJ; Xu Y; Sharkey FE; Wang P; Liu J
    bioRxiv; 2023 Sep; ():. PubMed ID: 37781601
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Yapping at the autophagy door? The answer is flowing in the kidney proximal tubule.
    Claude-Taupin A; Terzi F; Codogno P; Dupont N
    Autophagy; 2024 Jun; 20(6):1465-1466. PubMed ID: 38362917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular study of a Hoxa2 gain-of-function in chondrogenesis: a model of idiopathic proportionate short stature.
    Deprez PM; Nichane MG; Lengelé BG; Rezsöhazy R; Nyssen-Behets C
    Int J Mol Sci; 2013 Oct; 14(10):20386-98. PubMed ID: 24129174
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Yes-Associated Protein 1: Role and Treatment Prospects in Orthopedic Degenerative Diseases.
    Xie W; Xiao W; Tang K; Zhang L; Li Y
    Front Cell Dev Biol; 2020; 8():573455. PubMed ID: 33178690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of ERK 1/2 pathway downregulates YAP1/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions.
    Joddar B; Loyola CD; Ramirez SP; Singh I
    Biochem Biophys Res Commun; 2023 Mar; 648():72-80. PubMed ID: 36736094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An Anti-TAZ Monoclonal Antibody Recognizing Cell Surface Expressed TAZ Protein in Human Tumor Cells.
    Haji Ghaffari M; Mohammadzadeh M; Simonian M; Hashemi M; Sadeghi N; Negahdari B; Mazloomi M; Rabbani H
    Avicenna J Med Biotechnol; 2023; 15(1):14-20. PubMed ID: 36789121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.
    Guasto A; Cormier-Daire V
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discordant interactions between YAP1 and polycomb group protein SCML2 determine cell fate.
    Boston AM; Dwead AM; Al-Mathkour MM; Khazaw K; Zou J; Zhang Q; Wang G; Cinar B
    iScience; 2023 Oct; 26(10):107964. PubMed ID: 37810219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis.
    Azad T; Janse van Rensburg HJ; Lightbody ED; Neveu B; Champagne A; Ghaffari A; Kay VR; Hao Y; Shen H; Yeung B; Croy BA; Guan KL; Pouliot F; Zhang J; Nicol CJB; Yang X
    Nat Commun; 2018 Mar; 9(1):1061. PubMed ID: 29535383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis.
    Deel MD; Slemmons KK; Hinson AR; Genadry KC; Burgess BA; Crose LES; Kuprasertkul N; Oristian KM; Bentley RC; Linardic CM
    Clin Cancer Res; 2018 Jun; 24(11):2616-2630. PubMed ID: 29514840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.